Mercer Global Advisors »

Neurogene shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $45k 1.4k 31.45

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us High Prof Etf (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl High Profit (DIHP)
American Centy Etf Tr Avan Us Smal Etf (AVSC)
Ishares Tr National Mun Etf (MUB)

View all positions for Mercer Global Advisors

Top funds holding Neurogene

Samsara BioCapital
Casdin Capital
Redmile Group
Rtw Investments
EcoR1 Capital
BlackRock
Baker Bros. Advisors
Balyasny Asset Management
Trails Edge Capital Partners
Toronto-Dominion Bank
Vanguard Capital Management
Jennison Associates
Citadel Advisors
Dr. Jeffrey R. Jay, M.D.
Arrowpoint Asset Management

View all funds holding Neurogene